Drug Interaction Report
This report displays the potential drug interactions for the following 2 drugs:
- Cycrin (medroxyprogesterone)
Interactions between your drugs
Applies to: Cycrin (medroxyprogesterone), adalimumab
Adalimumab may decrease the blood levels and effects of medroxyPROGESTERone. You may need a dose adjustment if you have been receiving medroxyPROGESTERone and are starting treatment with adalimumab. Likewise, if you have been receiving both medications, the dose of medroxyPROGESTERone may need to be adjusted when adalimumab is discontinued. Contact your doctor if your condition changes or you experience increased side effects. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
There are no known alcohol/food interactions with your selected drugs. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.